New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
17:32 EDTMPC, BCR, FOSL, FASTSAC Capital reports new stakes in Fossil, Marathon, Fastenal, C.R. Bard
News For FOSL;MPC;FAST;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 4, 2015
06:02 EDTMPCMarathon Petroleum reports Q2 EPS 64c, consensus 57c
Subscribe for More Information
August 3, 2015
07:01 EDTBCRC.R. Bard says CMS approves add-on payment for Lutonix DCB for inpatient use
Subscribe for More Information
July 31, 2015
08:43 EDTMPCMarathon Petroleum weakness creates attractive entry point, says RBC Capital
Subscribe for More Information
July 30, 2015
10:23 EDTBCRC.R. Bard management to meet with JMP Securities
Subscribe for More Information
09:25 EDTMPCOn The Fly: Pre-market Movers
Subscribe for More Information
07:22 EDTMPCMarathon Petroleum reports Q2 EPS $1.51, consensus $1.76
Subscribe for More Information
July 29, 2015
12:08 EDTMPCMarathon Petroleum board increases dividend 28% to 32c per share
Marathon Petroleum announced that its board of directors declared a dividend of 32c per share on common stock, a 28% increase from the 25c per-share dividend in the first quarter of 2015, after adjusting to reflect the two-for-one stock split that occurred during the second quarter. The dividend is payable September 10 to shareholders of record as of the close of business August 19.
July 24, 2015
16:22 EDTBCROn The Fly: Top stock stories for Friday
Subscribe for More Information
July 23, 2015
17:33 EDTBCRC.R. Bard sees Q3 EPS $2.21-$2.25, consensus $2.28
Subscribe for More Information
17:32 EDTBCRC.R. Bard raises FY15 EPS view to $9-$9.10 from $8.95-$9.05, consensus $9.02
16:29 EDTBCRC.R. Bard reports Q2 adjusted EPS $2.27, consensus $2.18
Subscribe for More Information
15:04 EDTBCRNotable companies reporting after market close
Subscribe for More Information
July 21, 2015
10:01 EDTFASTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:27 EDTBCRFDA sent C.R. Bard warning letter after facility inspection
The FDA sent C.R. Bard a warning letter after inspecting the company's Peripheral Vascular facility. The letter stated in part, "FDA is aware that your firm submitted both in-vitro and in-vivo testing demonstrating the use of the Recovery Cone Removal System, Model RC-15 for removal of the Recovery Filter (K031328), the G2X Filter (K082305), the G2 Express Filter (K080668), and the G2 Filter (K073090). However, the Recovery Cone System, Model RC-15 was not included as part of the clearances for any of the aforementioned IVC filters. Therefore, your firm is marketing the Recovery Cone Removal System, Model RC-15 in the United States without marketing clearance or approval. Percutaneous retrieval systems, such as the Recovery Cone Removal System, Model RC-15, are regulated as manual surgical instruments intended for specialized use within a specific medical specialty, and thus require marketing authorization in order to be legally marketed in the United States." Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use